Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennemiek van Arkel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|August 4, 2023
Two opposing gene expression patterns within ATRX aberrant neuroblastomaMichael R van Gerven, Linda Schild, Jennemiek van Arkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2023
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138Jort J van der Schans, Ziyu Wang, Jennemiek van Arkel, et al.
Hemasphere|July 14, 2025
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapyJort J van der Schans, Paresh Vishwasrao, Renée Poels, et al.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Cancer Research|July 18, 2022
Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|August 4, 2023
Two opposing gene expression patterns within ATRX aberrant neuroblastomaMichael R van Gerven, Linda Schild, Jennemiek van Arkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2023
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138Jort J van der Schans, Ziyu Wang, Jennemiek van Arkel, et al.
Hemasphere|July 14, 2025
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapyJort J van der Schans, Paresh Vishwasrao, Renée Poels, et al.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Cancer Research|July 18, 2022
Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Pageof 1